| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3091f10096c97ee6f3516b719a48a2fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6a30890237a6d6d1647b273d0de55851
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c0cd00a6c5d4dc65492f4cde8fdc421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b06afb9b6f043bdd24f4a9721e1acd1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-21007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6435 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63 |
| filingDate |
2007-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25163c84129420d80a4f2d8e459dd594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_22ff72151559e91e9ad1caff1cc42f1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83e6d63f4940fb3a8f013f345c5a1ee4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b2479384a895be43b4665269bec9f12 |
| publicationDate |
2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009075369-A1 |
| titleOfInvention |
Angiostatin Fragments and Method of Use |
| abstract |
Fragments of an endothelial cell proliferation inhibitor and method of use therefor are provided. The endothelial proliferation inhibitor is a protein derived from plasminogen, or more specifically is an angiostatin fragment. The angiostatin fragments generally correspond to kringle structures occurring within the endothelial cell proliferation inhibitor. The endothelial cell inhibiting activity of these fragments provides a means for inhibiting angiogenesis of tumors and for treating angiogenic-mediated disease. |
| priorityDate |
1994-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |